Member Info for callit

@Sinden888 Just out of interest, is Volz Filters UK on your watch list too?

Any credit checks pop up over there?

This is genius! Diversification for shareholders and give the company a green wash. Improves our environmentally friendly stance for our other products that will give them a sales edge if they do it right. Lots of people are happy to pay more for something if it's helping the planet.

https://uk.yahoo.com/news/call-return-face-masks-covid-155720792.html

The world is awash with funding.
You can't change the world if you don't try Dr C!

https://www.ukri.org/opportunity/innovate-uk-smart-grants-jan-2023/

BRH didn't attribute any value to the masks in the example I posted because it was pre-covid being discovered.

It's not hard to understand that we used to sell Covid masks and that generated most of the revenue at the time. We don't sell Covid masks anymore and that's why the revenue is down. It has nothing to do with the rest of the business. Costs can be cut.

Been doing a little digging;

Covid was discovered in Jan 2020.
https://www.yalemedicine.org/news/covid-timeline

BRH invested 200k into P2F for an additional 18.39% in December 2019.
So that values the company at just short of 1.1m (before Covid with no mask or filter tech.)

https://www.lse.co.uk/rns/BRH/further-investment-in-pharm-2-farm-limited-4qx5rkyjln7y1tb.html

"Further investment in Pharm 2 Farm Limited



Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investment group, is pleased to report that it has completed a further investment of £200,000 into Pharm 2 Farm Limited ("P2F"), increasing its holding in P2F from 33.33 per cent. to 51.72 per cent.

This further investment will enable P2F to open a new manufacturing facility in Nottingham and expand its sales team to take advantage of the rapidly developing opportunities in agritech and other innovative applications.

P2F has developed a process to manufacture and coat nanoparticles which have been proven to increase the bioavailability of trace minerals in plant feeds. These trace materials enable plants to grow much more quickly and can be used by growers with their existing fertilisers, for both indoor and field crops. Traditionally, hydroponic plant growing has focused on crops like lettuce, micro-greens, strawberries, tomatoes, etc. In the future, high nutrition crops like chickpeas will need to be grown more quickly with multiple crops each year. The benefits of hydroponics include the ability to grow products closer to consumers, using less energy and producing less pollution, all of which can assist in balancing the needs of the world's population. P2F is also developing applications for the use of its technology in other areas, for example the pharmaceutical and medical sectors.

As at 31 August 2018, P2F had unaudited net liabilities of £17,631 and in the year ended 31 August 2018 incurred an unaudited loss of £20,011.

Trevor Brown, Chief Executive Officer said: "The interest shown in P2F products and technology since we acquired our original investment has significantly exceeded our expectations. As a result, we have decided to step up our investment immediately, thereby providing P2F the funds necessary to accelerate its business plan.""

The company has gone a long ways since. It has patents. It has research contracts. It has products in the nanoshot and the GBNano ready to go.

The MCAP is about the 2m mark, but would expect a placing to be done at a discount.

TB or anyone else could get a piece of this business for not much more than TB paid for it in 2019.

Will TB come back? Who knows?
DR C needs to be over there with a Toblerone and a big apology.

@ExMS First you tell us there is no demand for anti-pathogenic filters.
Then you tell us how well our competitors are doing.
Which is it?

Well we will wait and see. I hope you are wrong.

You are treating it as if that is certain. You don't know that some funding won't come from somewhere. They may never have the opportunity to do that.

The ink itself is of limited use since it is finite. That ink will run out.
They need a constant supply.

"A faster in line testing process is being developed to support scale up"

Maybe this needed more work than they thought and wasn't ready for the filtech date?

There is demand.

"HVAC manufacturers are particularly excited by our technology because they specifically strive to avoid using potentially toxic chemicals on air filters. These ethical companies believe you should not risk introducing any potentially harmful materials to the air supplied to human occupied environments, and we at Virosynth agree!"

Volz 'have everything they need'. We just thought it was to launch the product with us, rather than for them to take ownership of the whole show.

Even NNN would not be stupid enough to sink all their cash into producing nano ink if the ink wasn't going to be turned back into cash! Especially if it then meant the company would go under for lack of cash. Convinced they have a plan here.

#InCavewetrust

@UG they have the patents and a load of ink.
That's not nothing.

@ExMS What would be the point of adding him if they were closing up shop?
He must have something to add by being there.

Peter Gray is the king of M&A. Got to wonder; Why was he added to the Virosynth team?

Is he looking at selling it out to Volz or another?

So we can take the cash injection and concentrate on the myriad of other opportunities that have been identified, some of which could be imminent.

https://www.business-money.com/announcements/manchester-based-volz-filters-acquires-with-500000-funding-from-santander/

"VOLZ Filters UK Ltd’s parent company, VOLZ Luftfilter GmbH & Co. KG, was established in 1966 in Germany by Manfred Volz and his wife Ella, with the UK arm set up in Manchester in 2006. The group now has over 700 employees and owns factories in Germany, Slovakia and the UK. In line with its growth-led expansion plan, VOLZ aims to acquire additional businesses in the UK on a select, long-term basis that complement its UK product and service proposition."

Be ready for the next one.

"“I think we’re seeing a genuine increase in some of these diseases,” says Dr Dunning, who argues that climate change, globalisation and deforestation is bringing humanity and nature into ever-closer proximity with one another, increasing the risk of zoonotic outbreaks."

https://uk.yahoo.com/finance/news/britain-terrifying-isolation-tent-patients-131710268.html

I think it would have gone down better with investors if Zen had just said that our offer had been accepted though I understand why they may want to downplay this since we got shafted in Congo after that point. Investors are now mindful that nothing short of the PSC is 100% certain, but I still see it as a positive step.

It seems to me from the RNS that finalisation takes place AFTER and only IF our offer has been accepted? Is that how other people read this too?

"If Zenith's Offer for Block-1 is accepted, Zenith will progress in completing a rigorous due diligence process and begin negotiations with the Ministry aimed at finalising a draft Production Sharing Agreement to be approved by the legislature of Benin (in accordance with the Hydrocarbon Code)."

GLA DYOR

"Progress continues with the development of the Serenity oil discovery in the Central North Sea alongside our partner i3 Energy

· Despite drilling an appraisal well in October 2022 that failed to encounter hydrocarbons, the partners believe that Serenity offers a commercially viable development opportunity with a number of potential development scenarios available given local infrastructure

· A future development could result in approximately 1,000 bopd net to Europa's 25% interest"

https://www.lse.co.uk/rns/ZEN/new-strategic-investor-in-zenith-netherlands-nbkittbzmw9xiaa.html

https://www.zenithenergy.ca/about/team/#sergey-borovskiy